» Articles » PMID: 24928910

Host Factors Determine Differential Disease Progression After Infection with Nef-deleted Simian Immunodeficiency Virus

Overview
Journal J Gen Virol
Specialty Microbiology
Date 2014 Jun 15
PMID 24928910
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Infection of macaques with live attenuated simian immunodeficiency virus (SIV) usually results in long-lasting efficient protection against infection with pathogenic immunodeficiency viruses. However, attenuation by deletion of regulatory genes such as nef is not complete, leading to a high viral load and fatal disease in some animals. To characterize immunological parameters and polymorphic host factors, we studied 17 rhesus macaques infected with attenuated SIVmac239ΔNU. Eight animals were able to control viral replication, whereas the remaining animals (non-controllers) displayed variable set-point viral loads. Peak viral load at 2 weeks post-infection (p.i.) correlated significantly with set-point viral load (P<0.0001). CD4(+) T-cell frequencies differed significantly soon after infection between controllers and non-controllers. Abnormal B-cell activation previously ascribed to Nef function could already be observed in non-controllers 8 weeks after infection despite the absence of Nef. Two non-controllers developed an AIDS-like disease within 102 weeks p.i. Virus from these animals transmitted to naïve animals replicated at low levels and the recipients did not develop immunodeficiency. This suggested that host factors determined differential viral load and subsequent disease course. Known Mhc class I alleles associated with disease progression in SIV WT infection only marginally influenced the viral load in Δnef-infected animals. Protection from SIVmac251 was associated with homozygosity for MHC class II in conjunction with a TLR7 polymorphism and showed a trend with initial viral replication. We speculated that host factors whose effects were usually masked by Nef were responsible for the different disease courses in individual animals upon infection with nef-deleted viruses.

Citing Articles

Increased BST2 expression during simian immunodeficiency virus infection is not a determinant of disease progression in rhesus monkeys.

Mussil B, Javed A, Topfer K, Sauermann U, Sopper S Retrovirology. 2015; 12:92.

PMID: 26554913 PMC: 4641394. DOI: 10.1186/s12977-015-0219-8.


Immunogenetic characterization of a captive colony of sooty mangabeys (Cercocebus atys) used for SIV research.

Smith G, Bauer L, Crane M, Johnson Z J Med Primatol. 2015; 44(2):76-88.

PMID: 25645218 PMC: 4378528. DOI: 10.1111/jmp.12161.

References
1.
Fukazawa Y, Park H, Cameron M, Lefebvre F, Lum R, Coombes N . Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines. Nat Med. 2012; 18(11):1673-81. PMC: 3493820. DOI: 10.1038/nm.2934. View

2.
Sharpe S, Cope A, Dowall S, Berry N, Ham C, Heeney J . Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope. J Gen Virol. 2004; 85(Pt 9):2591-2602. DOI: 10.1099/vir.0.80050-0. View

3.
Sauermann U, Siddiqui R, Suh Y, Platzer M, Leuchte N, Meyer H . Mhc class I haplotypes associated with survival time in simian immunodeficiency virus (SIV)-infected rhesus macaques. Genes Immun. 2007; 9(1):69-80. DOI: 10.1038/sj.gene.6364448. View

4.
Moir S, Fauci A . B cells in HIV infection and disease. Nat Rev Immunol. 2009; 9(4):235-45. PMC: 2779527. DOI: 10.1038/nri2524. View

5.
Stolte-Leeb N, Sauermann U, Norley S, Fagrouch Z, Heeney J, Franz M . Sustained conservation of CD4+ T cells in multiprotein triple modality-immunized rhesus macaques after intrarectal challenge with simian immunodeficiency virus. Viral Immunol. 2006; 19(3):448-57. DOI: 10.1089/vim.2006.19.448. View